Point: The relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: Is there an elephant in the room?

被引：17
作者：
Morris, W. James [1 ]
Halperin, Ross [2 ]
Spadinger, Ingrid [1 ]
机构：
[1] British Columbia Canc Agcy, Dept Radiat Oncol, Vancouver, BC V5Z 4E6, Canada
[2] British Columbia Canc Agcy, Dept Radiat Oncol, Kelowna, BC, Canada
来源：
BRACHYTHERAPY | 2010年 / 9卷 / 04期
关键词：
RELATIVE BIOLOGICAL EFFECTIVENESS; INTEROBSERVER VARIABILITY; I-125; OUTCOMES; IMPLANT; CANCER; DOSIMETRY; FAILURE; PD-103;
D O I：
10.1016/j.brachy.2010.08.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：289 / 292
页数：4
相关论文
共 18 条
[1]   Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry [J].
Al-Qaisieh, B ;
Ash, D ;
Bottomley, DM ;
Carey, BM .
RADIOTHERAPY AND ONCOLOGY, 2002, 62 (03) :267-273
[2]   Sector analysis of prostate implants [J].
Bice, WS ;
Prestidge, BR ;
Sarosdy, MF .
MEDICAL PHYSICS, 2001, 28 (12) :2561-2567
[3]   A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients [J].
Butler, Wayne M. ;
Stewart, Renee R. ;
Merrick, Gregory S. .
MEDICAL PHYSICS, 2009, 36 (03) :776-787
[4]  
Choi S, 2004, CANCER J, V10, P175
[5]  
Crook Juanita, 2002, Brachytherapy, V1, P66, DOI 10.1016/S1538-4721(02)00014-4
[6]   Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy [J].
Dubois, DF ;
Prestidge, BR ;
Hotchkiss, LA ;
Prete, JJ ;
Bice, WS .
RADIOLOGY, 1998, 207 (03) :785-789
[7]   RADIATION DOSE PREDICTS FOR BIOCHEMICAL CONTROL IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS TREATED WITH LOW-DOSE-RATE BRACHYTHERAPY [J].
Ho, Alice Y. ;
Burri, Ryan J. ;
Cesaretti, Jamie A. ;
Stone, Nelson N. ;
Stock, Richard G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (01) :16-22
[8]   125I monotherapy using D90 implant doses of 180 GY or greater [J].
Kao, Johnny ;
Stone, Nelson N. ;
Lavaf, Amir ;
Dumane, Vishruta ;
Cesaretti, Jamie A. ;
Stock, Richard G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (01) :96-101
[9]   Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy [J].
Lee, WR ;
Roach, M ;
Michalski, J ;
Moran, B ;
Beyer, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02) :457-461
[10]   The influence of brachytherapy dose heterogeneity on estimates of α/β for prostate cancer [J].
Lindsay, PE ;
Moiseenko, VV ;
Van Dyk, J ;
Battista, JJ .
PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (04) :507-522
12